What is the most likely cause of macrocytic anemia in a patient with bipolar disorder on mood‑stabilizing anticonvulsants, a history of stroke with hemiparesis, constipation, spinocerebellar ataxia, and post‑anoxic encephalopathy?

Drug-Induced Macrocytic Anemia from Anticonvulsant Therapy

The macrocytic anemia in this patient is most likely caused by anticonvulsant medications used for bipolar disorder and seizure management, specifically drugs like valproate, carbamazepine, or lamotrigine. 1

Clinical Reasoning

Key Laboratory Findings Analysis

The patient presents with:

• MCV 99.6 fL (borderline macrocytic, just at the threshold of >100 fL)
• Low reticulocyte count 1.14% (indicating hypoproliferative anemia)
• Elevated CRP 89.4 mg/L (significant inflammation)
• Normal haptoglobin 2.75 g/L (excludes hemolysis)
• Elevated platelets 472 ×10³/µL (reactive thrombocytosis from inflammation)

This constellation points to a non-megaloblastic macrocytic anemia with decreased RBC production 1.

Why Anticonvulsants Are the Primary Culprit

Anticonvulsants are recognized causes of macrocytosis through non-megaloblastic mechanisms 1. The guidelines specifically identify:

• Diphenytoin (phenytoin)
• Valproate
• Carbamazepine
• Other mood-stabilizing anticonvulsants

These medications are standard treatment for bipolar disorder 2 and are used in this patient's complex neurological history (spinocerebellar ataxia, post-anoxic encephalopathy, stroke).

Critical distinction: While anticonvulsants can cause low serum folate levels (83% of patients on long-term therapy), the development of macrocytic anemia is NOT related to this biochemical folate depletion but rather reflects the direct drug effect on erythropoiesis 3. Research from 1978 demonstrated that only 1% of patients on anticonvulsants developed macrocytic anemia despite 83% having low folate levels 3.

Differential Considerations

Vitamin B12/Folate Deficiency: Less likely because:

• MCV is only borderline elevated (99.6 fL vs typical >110 fL for megaloblastic anemia) 4
• No neurological symptoms specifically attributable to B12 deficiency (existing neurological issues are from other causes)
• Anticonvulsant-induced folate deficiency rarely causes true macrocytic anemia 3

Anemia of Chronic Disease: Contributing factor given:

• Elevated CRP (89.4 mg/L)
• Low reticulocyte count
• However, ACD typically causes normocytic or microcytic anemia, not macrocytosis 5

Hypothyroidism: Should be excluded but less likely given the clinical context 5

Myelodysplastic Syndrome: Unlikely given patient's age and clinical context, though should be considered if anemia doesn't respond to intervention 1

Diagnostic Workup Required

Immediate testing needed:

1. Vitamin B12 and folate levels - mandatory to exclude deficiency despite anticonvulsant use being more likely 5
2. Thyroid function tests (TSH, free T4) - hypothyroidism causes macrocytosis 5
3. Peripheral blood smear review - distinguish megaloblastic from non-megaloblastic morphology 1
4. Medication list review - identify specific anticonvulsants and other potential causative drugs

If B12 is low-normal (150-250 pmol/L), measure methylmalonic acid (MMA) to confirm true deficiency, as B12 levels can be misleading 6, 7.

Management Algorithm

Step 1: Exclude Nutritional Deficiencies

• If B12 <150 pmol/L or MMA elevated: Treat immediately with hydroxocobalamin 1 mg IM three times weekly for 2 weeks, then every 2-3 months 7
• If folate deficient: Give folic acid 5 mg daily for minimum 4 months, but only after excluding B12 deficiency to prevent subacute combined degeneration 7

Step 2: Address Anticonvulsant Therapy

• Do NOT discontinue anticonvulsants without psychiatric/neurological consultation given bipolar disorder and seizure history
• Consider switching to alternative mood stabilizers with lower hematological impact if clinically appropriate
• Monitor CBC every 3-6 months while on anticonvulsants 7

Step 3: Treat Underlying Inflammation

• CRP of 89.4 mg/L suggests active inflammatory process
• Address source of inflammation (infection, tissue damage from stroke sequelae)
• Inflammation contributes to anemia through hepcidin-mediated mechanisms 5

Step 4: Monitor Response

• Recheck hemoglobin in 4 weeks
• Expected response: Increase of ≥2 g/dL if nutritional deficiency was present 5
• If no response, consider hematology referral for bone marrow evaluation to exclude MDS 1

Critical Pitfalls to Avoid

1. Do NOT give folic acid before excluding B12 deficiency - can precipitate irreversible neurological damage 7
2. Do NOT assume low folate on anticonvulsants equals megaloblastic anemia - the relationship is not causal 3
3. Do NOT overlook inflammation - elevated CRP indicates anemia of chronic disease component requiring separate management 5
4. Do NOT stop anticonvulsants abruptly - risk of seizures and mood destabilization outweighs mild macrocytosis 2